Sanguine BioSciences is a biotechnology company bridging the gap between patients and researchers by providing transparency throughout the personalized medicine R&D process. Sanguine collects and de-identifies patient-derived data in the form of biospecimen and physician and self-reported information. These data are generated and then made available to researchers involved in drug and biomarker research and discovery.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/22/13 | undisclosed | Seed |
Heliant Ventures | undisclosed |
